DiaSorin (OTCMKTS:DSRLF) Shares Gap Up – Here’s What Happened

DiaSorin S.p.A. (OTCMKTS:DSRLF) gapped up prior to trading on Wednesday . The stock had previously closed at $67.00, but opened at $80.35. DiaSorin shares last traded at $80.35, with a volume of 100 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Zacks Research raised DiaSorin to a “hold” rating in a report on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of DiaSorin in a research report on Tuesday, February 10th. Finally, UBS Group downgraded DiaSorin from a “buy” rating to a “neutral” rating in a research note on Thursday, April 9th. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

DiaSorin Stock Up 19.9%

The company has a 50-day moving average price of $68.57 and a two-hundred day moving average price of $74.41.

About DiaSorin

DiaSorin S.p.A. is an Italy‐based global biotechnology company specializing in the development, manufacture and marketing of in vitro diagnostic products. Headquartered in Saluggia, DiaSorin serves clinical laboratories, hospitals and physician offices with a broad portfolio of immunodiagnostic assays and molecular diagnostic tests. The company’s shares trade on the Milan Stock Exchange and are available in the United States as over‐the‐counter (OTC) securities under the symbol DSRLF.

At the core of DiaSorin’s business are immunodiagnostic systems that measure antibodies, antigens and hormones in human samples.